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Abstract
Background: A test for diagnosis of active Tuberculosis (TB) from peripheral blood could tremendously improve clinical
management of patients.
Methods: Of 178 prospectively enrolled patients with possible TB, 60 patients were diagnosed with pulmonary and 27
patients with extrapulmonary TB. The frequencies of Mycobacterium tuberculosis (MTB) specific CD4
+ T cells and CD8
+ T cells
producing cytokines were assessed using overnight stimulation with purified protein derivate (PPD) or early secretory
antigenic target (ESAT)-6, respectively.
Results: Among patients with active TB, an increased type 1 cytokine profile consisting of mainly CD4
+ T cell derived
interferon (IFN)-c was detectable. Despite contributing to the cytokine profile as a whole, the independent diagnostic
performance of one cytokine producing T cells as well as polyfunctional T cells was poor. IFN-c/Interleukin(IL)-2 cytokine
ratios discriminated best between active TB and other diseases.
Conclusion: T cells producing one cytokine and polyfunctional T cells have a limited role in diagnosis of active TB. The
significant shift from a ‘‘memory type’’ to an ‘‘effector type’’ cytokine profile may be useful for further development of a
rapid immune-diagnostic tool for active TB.
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Introduction
Tuberculosis (TB) remains to be a global health care problem
and together with malaria and HIV is considered to be one of the
three key infectious diseases worldwide [1]. The improvement
of clinical management of active TB relies primarily on the
unambiguous diagnosis of the disease. However, a rapid and
straightforward test to confirm or rule out active TB is lacking in
clinical routine [2]. Indeed, a diagnostic test for diagnosis of active
TB from an easily accessible compartment such as peripheral
blood could significantly improve patient management.
Such a test appeared to be in reach after the discovery of
Mycobacterium tuberculosis (MTB) specific antigens and their use for
T cell stimulation assays based on Enzyme Linked Immuno
Spot Technique (ELISPOT) and Enzyme-Linked Immunosorbent
Assay (ELISA) techniques [3,4]. Both tests rely on in vitro
produced interferon (IFN)- c as read out and have been shown to
introduce increased sensitivity and specificity for the diagnosis of
latent TB infection [5]. Disappointingly, however, the tests are not
suitable for the diagnosis of active TB [4].
A flow cytometry based read out has been suggested to possibly
improve the diagnostic accuracy of MTB specific stimulation
assays, because MTB specific T cell subsets producing different
types of cytokines can be analysed on a single cell basis [6]. T cells
producing single cytokines [7], two cytokines – ‘‘polyfunctional T
cells [8]’’ - and three cytokines - ‘‘multifunctional T cells [9,10]’’ –
have been linked to bacterial load and disease activity. More
recently CD4
+ T cells producing single tumor necrosis factor
(TNF)-a have been suggested to differentiate between active TB
and latent infection [7]. Moreover, cytokines generally regarded as
pro-inflammatory such as TNF-a, IFN-c and Interleukin (IL)-2
were associated with active TB as well as regulatory cytokines like
IL-10 and transforming growth factor (TGF)-b [11–13]. Thus, we
hypothesised that a distinct cytokine profile could be useful for the
diagnosis of active TB.
The recent investigation was conducted to prospectively assess
sensitivity and specificity of MTB specific, one cytokine producing
and polyfunctional T cells in patients with the clinical suspicion of
active TB to possibly discover an MTB specific cytokine signature.
Materials and Methods
1. Patients
Patient recruitment was confined to the wards of the Medical
University of Vienna (Division of Infectious Diseases and Tropical
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Medicine at the Otto-Wagner Hospital in Vienna, Austria.
Written informed consent was obtained from all participating
individuals. Human experimentation guidelines of the Medical
University of Vienna were followed during the clinical research.
Ethical clearance was given by the Ethics Committee of the
Medical University of Vienna and the Viennese Krankenanstal-
tenverbund.
Patients presenting with signs and symptoms suggestive of TB
were eligible for this study. Human immunodeficiency (HI)-virus
infected patients were not included in the study. All study
participants had a history of BCG vaccination (in Austria BCG
vaccination was stopped in 1990; countries of origin of all other
study participants (e.g. Russian Federation, Serbia, Romania,
Ukraine, Bulgaria,…) are still administering BCG vaccines. No
history of previous TB was reported by any of the patients. The
presence of latent MTB-infection was not generally looked at, as it
was the purpose of the study to potentially differentiate active TB
from other diseases. According to the attending physicians, the pre-
test probability for TB in this study population was approximately
30%, taking in account the history, social background, signs and
symptoms. Approximately 27 ml of blood were drawn for the
isolation of peripheral blood mononuclear cells (PBMC) during
initial assessment.
Pulmonary TB was defined by the presence of the following
criteria: detection of MTB by culture or PCR in sputum or
bronchoalveolar fluid obtained by bronchoalveolar lavage (BAL)
and the clinical diagnosis of pulmonary TB with the concomitant
initiation of a tuberculostatic drug therapy. Extra-pulmonary TB
was defined by the detection of MTB in other tissue than the
lungs, the clinical diagnosis of active TB disease and the initiation
of treatment.
If MTB was not detectable by culture or PCR, the
unambiguous clinical diagnosis and the initiation of a tuberculo-
static drug therapy was required to fulfil the diagnosis of active TB.
In these cases, active TB infection was diagnosed by the presence
of necrotizing granulomatous inflammation without other causes,
clinical history suggestive of active TB, including at least three of
the following symptoms: night sweat, unintended weight loss,
malaise, fever, lassitude and known exposure to open TB.
Additionally, the absence of another diagnosis and the clinical
response to tuberculostatic drugs was evaluated.
Importantly, doctors involved in clinical management and
decision making were completely unaware of the results of the
stimulation assays.
2. Methods
PBMC were isolated from heparinized blood by ficoll-
diatrizoate centrifugation, and plated out into 24-well plates
(BD Falcon, Mountain View, CA, USA) at 2610
6 per well. Cells
were cultured in ultra-culture medium (UCM) (Bio Whittaker,
Walkersville, MD, USA) supplemented with L-glutamine (2 mM/
L; Sigma, St. Louis, MI, USA), gentamicin (170 mg/l; Sigma)
and 2-mercaptoethanol (3.5 ml/L; Merck, Darmstadt, Germany)
for 18 h at 37uC in 5% CO2 and stimulated with purified protein
derivate (PPD) (Statens Serum Institute, Copenhagen, Denmark),
at a final concentration of 10 mg/mL or with early secretory
antigenic target (ESAT)-6 (Statens Serum Institute, Copenhagen,
Denmark) with a final concentration of 5 mg/ml. In order to
amplify TCR signalling and to facilitate the initial phase of the T-
cell activation, the co-stimulatory MAb CD28 (Pharmingen San
Diego, CA, USA), was added at a final concentration of 5 mg/
mL. Brefeldin A (10 mg/mL final concentration, Sigma) was
added after 6 h to block protein secretion. After 18 h, cells were
harvested on ice, washed twice in phosphate-buffered saline
(PBS), and fixed with 2% formaldehyde (1 mL per 2610
6 cells)
for 20 minutes. After two additional washes in PBS, the cells were
re-suspended in Hank’s balanced salt solution (supplemented with
0.3% bovine serum albumin and 0.1% sodium-azide). The cells
were washed twice with PBS and made permeable with saponin
(0.1%; Sigma), re-suspended with 50 mL of saponin-buffered
diluted antibodies and incubated for 25 minutes in the dark. The
following monoclonal antibodies were used: Anti-CD4, PerCP
and APC labelled, Anti-CD8, PerCP labelled (Becton and
Dickinson, Mountain View, CA); Anti-TGF-b, PE labelled
(IQProducts, Groningen, The Netherlands); MAb IFN-c (clone:
B 27), fluorescein–isothiocyanate (FITC) labelled; MAb IL–2
(clone: MQ1-17H12), PE labelled; MAb IL-10 (clone: JES3-9D7),
PE labelled; MAb TNF–a (clone: MAB -11), PE labelled (all
Becton and Dickinson). Four-color staining was performed, and a
minimum of 10
5 PBMCs were analysed on a FACS-Calibur
Figure 1. Representative dot plots. Representative two-parameter dot plots of a patient with extrapulmonary TB (urogenital TB) indicating the
frequency of PPD and ESAT-6-specific CD4
+ T cells expressing IFN-c and/or IL-2, respectively. PBMC were incubated with medium alone (control), PPD
and ESAT-6, respectively.
doi:10.1371/journal.pone.0035290.g001
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630-nm wavelength, respectively) (Figure 1). All cytokine
combinations were stained in conjunction with CD4 and CD8.
The data were analysed with CELL-Quest software (Becton
Dickinson) and the results were expressed as the percentage of
cytokine-producing cells in each CD4
+ or CD8
+ population. To
assure specificity, spontaneous cytokine production in control
wells was subtracted from cytokine production after stimulation
with PPD or ESAT-6.
3. Statistics
Statistical analysis was performed using SPSS 15.0 for
Windows, SPSS Inc., Chicago. The independent-samples T-test
was applied to screen for differences between 2 groups. A one-way
between-groups analysis of variance (ANOVA) with a Tukey post-
hoc test was used for 3 groups. Direct logistic regression
was calculated between the following groups: pulmonary TB and
non-TB diseases, extrapulmonary TB and non-TB diseases,
pulmonary and extrapulmonary TB. Cytokine ratios were
calculated by dividing the total percentages of the respective
cytokine. Receiver-operating-characteristic curves (ROC) were
calculated and expressed as areas under the curve (AUC), with an
asymptotic 95% confidence interval (CI). A p-value of ,0.05 (two
tailed) was considered significant.
Results
1. Patients
A total of 178 patients were included in the study. 112 were men
(62.9%) and 66 were women (37.1%). 60 patients were classified as
suffering from pulmonary TB, 27 from extrapulmonary TB and
91 from non-TB diseases. Patient details are depicted in Table 1.
Clinical characteristics and total MTB specific CD4
+IFN-c
+ T
Table 1. Patient characteristics.
diagnosis
number of
individuals,
total: 178
male/female
total: 112/66
age (median, min–max)
total: 47.4 (14.8–86.5)
MTB
confirmation
total: 85.1%
histological
evidence of TB
pulmonary TB 60 39/21 42.8 (17.8–86.5) 55 (91.7%) 11 (18.3%)
extra pulmonary TB (n=27) bone TB 2 1/1 24.1 (21.3–26.9) 1 (100%)
TB lymphadenopathy 3 1/1 29.9 (25.8–33.5) 3 (100%) 1 (50%)
miliary TB 2 0/2 31.8 (24.7–38.9) 2 (100%)
peritoneal TB 4 3/1 31.7 (14.7–84.2) 1 (25%) 3 (75%)
soft tissue TB 5 2/3 58.8 (29.9–82.6) 4 (80%) 3 (60%)
liver TB 1 0/1 72 1 (100%)
TB meningitis 2 1/1 38 (18.2–57.8) 2 (100%)
joint TB 2 1/1 57.8 (46.1–69.5) 1 (50%) 2 (100%)
TB pericarditis 1 0/1 47.3 1 (100%) 1 (100%)
TB pleuritis 3 2/1 31.3 (17.8–52) 1 (33.3%)
urogenital TB 2 0/2 44.8 (22.6–67) 1 (100%) 1 (100%)
non-TB diseases (n=91) bacterial peritonitis 1 1/0 53.4
cancer 26 17/9 58.4 (30.9–84.0)
bronchitis 2 1/1 39.4 (36.8–42.1)
CKR changes of unknown origin 13 10/3 53 (28–64.4)
pneumonia 26 18/8 46.3 (20.6–78.1)
liver cirrhosis 1 1/0 56.2
COPD
1 4 3/1 51.8 (50–69.8)
viral encephalitis 1 1/0 56.4
fibrosis of the lung 3 1/3 26.0 (24.7–59.8)
M.chelonae
2 1 0/1 73.2
M.kansasii
2 2 0/2 47.7 (47.6–47.9)
M.xenopi
2 2 1/1 64.7 (51.1–78.5)
idiopathic pericarditis 1 0/1 37.8
pneumoconiosis 1 1/0 77.2
rheumatoid arthritis 1 1/0 42.8
sarcoidosis 2 0/2 68.7 (66.8–70.6)
septic arthritis 1 1/0 53.2
idiopathic polyserositis 2 1/1 53 (24.3–81.7)
silicosis 1 0/1 42.7
1chronic obstructive pulmonary disease.
2infection with non-tuberculous mycobacteria.
doi:10.1371/journal.pone.0035290.t001
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[14].
2. Frequencies of MTB-specific T cells
2.1. Differences between pulmonary TB and diseases
other than TB. An independent-samples t-test showed an
increased frequency of CD4
+ T cells expressing IFN-c
(p=0.034) and a significantly decreased frequency of CD4
+ T
cells expressing IL-2 (p=0.037) - both ESAT-6 specific - in
patients with pulmonary TB when compared to diseases other
then TB (Figure 2). With regard to PPD stimulated T cells no
differences were found between TB and non-TB patients
(Figure 3).
Direct logistic regression was performed to assess the impact of
each single factor on the likelihood that patients would have
pulmonary TB or not. The full model containing age, sex,
CD4
+IFN-c
+ T cells, CD4
+IL-2
+ T cells was statistically
significant, X
2 (4 df)=34.465, p,0.001. The model as a whole
correctly classified 72.7% of the cases. Age (p,0.001), CD4
+IFN-
c
+ T cells (p=0.033), CD4
+IL-2
+ T cells (p=0.032) made a
unique statistically significant contribution to the model. A
Receiver-operating-characteristic curve (ROC) was calculated
and expressed as area under the curve (Figure 4), with an
asymptotic 95% confidence interval (CI).
2.2. Differences between extrapulmonary TB and
diseases other than TB. An independent-samples t-test
showed decreased frequency of PPD specific CD4
+IFN-c
+IL-10
+
T cells (p=0.007) and an increased frequency of ESAT-6 specific
CD4
+IFN-c
+ T cells (p=0.037) (Figures 2, 3). Direct logistic
regression was performed to assess the impact of each single factor
on the likelihood that patients would have extrapulmonary TB or
not. The full model containing age, sex, PPD specific CD4
+IFN-
c
+IL-10
+ T cells and ESAT-6 specific CD4
+IFN-c
+ T cells was
statistically significant, X
2 (7 df)=33.2 p,0.001. The model as a
whole correctly classified 82.2% of the cases. Age (p=0.006) and
CD4
+IFN-c
+ T cells (p=0.015) made a unique statistically
significant contribution to the model. A Receiver-operating-
characteristic curve (ROC) was calculated and expressed as area
under the curve (Figure 4), with an asymptotic 95% confidence
interval (CI) (summarized in Table 2).
2.3. Differences between extrapulmonary and pulmonary
TB. An independent-samples t-test showed an increased
frequency of PPD specific CD8
+ T cells expressing IL-2
(p=0.011) and ESAT-6 specific CD8
+ T cells expressing IFN-c
and TNF-a
+ (p=0.041) (Figures 2, 3). Direct logistic regression
was performed to assess the impact of each single factor on the
likelihood that patients would have extrapulmonary or pulmonary
Figure 2. Frequencies of ESAT-6 specific T cells. Frequencies of
single cytokine producing T cells and multifunctional T cells of 60
patients with pulmonary TB (light grey), 27 extrapulmonary TB (dark
grey) and 91 with non-tuberculous diseases (white) after overnight
stimulation with ESAT-6 are depicted. Boxes and whiskers are shown;
the black line marks the median. Differences between patient groups
are marked with a bar. A significantly increased frequency of CD4
+ T
cells expressing IFN-c (0; 0–0; 0–0.07 vs. 0; 0–0.02; 0–0.3 or 0; 0–0.03; 0–
0.3 [median; 25%–75% percentile; min–max], respectively. p=0.034)
and a decreased frequency of CD4
+ T cells expressing IL-2 (0; 0–0.02; 0–
0.26 vs. 0; 0–0.01; 0–0.06 [median; 25%–75% percentile; min–max].
p=0.037) were found in patients with pulmonary TB when compared to
diseases other then TB. CD8
+ T cells expressing IFN-c and TNF-a
+ (0; 0–
0.02; 0–0.16 vs. 0.02 ; 0–0.05; 0–0.23 [median; 25%–75% percentile; min–
max]. p=0.041) were different when pulmonary and extrapulmonary TB
were compared. An independent-samples t-test was used to test for
significance.
doi:10.1371/journal.pone.0035290.g002
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+IL-2
+
T cells and ESAT-6 specific CD8
+IFN-c
+TNF-a
+ T cells was
statistically significant, X
2 (4 df)=22.286, p,0.001. The model as
a whole correctly classified 74.4% of the cases. PPD specific
CD8
+IL-2
+ T cells (p=0.004) and ESAT-6 specific CD8
+IFN-
c
+TNF-a
+ T cells (p=0.031) made a unique statistically significant
contribution to the model. A Receiver-operating-characteristic
curve (ROC) was calculated and expressed as area under the curve
(Figure 4), with an asymptotic 95% confidence interval (CI)
(summarized in Table 2).
2.4. Differences of cytokine ratios between groups. A
one way between-groups analysis of variance using the tukey test
for post hoc analysis was conducted to explore the impact of
different cytokine ratios between pulmonary TB, extrapulmonary
TB and other diseases than TB (displayed in Figure 5, the
percentile ranges of the box and whiskers are depicted in Tables 3,
4, 5).
The following cytokine ratios were found to be different
between non-TB diseases and pulmonary TB: PPD induced
IFN-c/IL-2 (p,0.001) and ESAT-6 induced TNF-a/IFN-c
(p=0.048). TNF-a/IL-2 (p=0.03), and IFN-c/IL-2 (p=0.005).
All were CD4
+ T cell derived.
The following cytokine ratios were found to be different
between non-TB diseases and extrapulmonary TB: PPD induced
TNF-a/IL-2 (p,0.001), IFN-c/IL-2 (p=0.001) and ESAT-6
induced TNF-a/IFN-c (p=0.026), TNF-a/IL-2 (p=0.008), and
IFN-c/IL-2 (p,0.001). All were CD4
+ T cell derived.
The following cytokine ratio was found to be different between
pulmonary and extrapulmonary TB: PPD induced TNF-a/IL-2
(p=0.001), CD4
+ T cell derived.
For each cytokine ratio, a receiver-operating-characteristic
curve (ROC) was calculated and expressed as area under the
curve with an asymptotic 95% confidence interval (CI). The
highest AUCs to discriminate between pulmonary TB and other
diseases 20.704 and 0.654 - were the ratios of IFN-c divided by
IL-2, induced by PPD and ESAT-6, respectively. The highest
AUCs to discriminate between extrapulmonary TB and other
diseases 20.756 and 0.712 - were the ratios of PPD induced IFN-c
and TNF-a, divided by IL-2, respectively (Figure 4, summarized in
Table 2).
Discussion
In this prospective clinical study a type 1 cytokine profile specific
for both pulmonary and extrapulmonary TB was detected,
consisting of a robust production of IFN-c by MTB-specific
CD4
+ T cells. Neither one cytokine producing T cells nor
polyfunctional T cells appeared to have a useful diagnostic value
on their own. In contrast, a relative shift from IL-2 towards IFN-c
production in T cells was associated with active TB, suggesting
that cytokine ratios might introduce more discriminatory power
than assessing single cytokine producing T cells.
Figure 3. Frequencies of PPD specific T cells. Frequencies of single
cytokine producing T cells and multifunctional T cells of 60 patients with
pulmonary TB (light grey), 27 extrapulmonary TB (dark grey) and 91
with non-tuberculous diseases (white) after overnight stimulation with
PPD are depicted. Boxes and whiskers are shown; the black line marks
the median. CD4
+IFN-c
+IL-10
+ T cells (0.01 ; 0.02–0.33; 0–0.16 vs. 0; 0–
0.01; 0–0.08 [median; 25%–75% percentile; min–max]. p=0.007) were
significantly different when extrapulmonary TB was compared to other
diseases then TB. Comparing pulmonary and extrapulmonary TB, PPD
specific CD8
+ T cells expressing IL-2 (0.14 ; 0.09–0.365; 0–4.61 vs. 0.13;
0.06–0.33; 0–2.93 [median; 25%–75% percentile; min–max]. p=0.011)
were significantly different. Differences between patient groups are
marked with a bar. An independent-samples t-test was used to test for
significance.
doi:10.1371/journal.pone.0035290.g003
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restricted to increased frequencies of CD4
+IFN-c
+ T cells and
decreased frequencies of CD4
+IL-2
+ T cells, contributing
independently to the logistic regression model. Disappointingly,
the AUC for the respective cytokines after ROC analysis were
comparatively low, limiting thereby their diagnostic value. The
independent increase of CD4
+IFN-c
+ ‘‘effector’’ T cells during
active – both pulmonary and extrapulmonary – TB is backed by
the recently published transcriptional signature for active TB,
consisting mainly of an interferon gene profile [15].
The decrease of IL-2 producing T cells – a functional
‘‘memory’’ equivalent [16] - is in line with published data,
showing that patients with active TB had decreased frequencies of
single IL-2 producing T cells if compared to their house hold
contacts [17].
In contrast to CD4
+IFN-c
+ T cells, TNF-a producing T cells
were not independently associated with active TB. In fact, TNF-a
producing CD4
+ T cells were not even statistically different
between patient groups, questioning their value as a diagnostic
tool. These results differ significantly from previously published
results, showing high association between active TB and T cells
producing single TNF-a [7,12]. This discrepancy could be due to
two main differences.
Firstly and in contrast to these previous investigations, the
control group in our recent study consisted of patients who
suffered from other diseases than TB. The control groups in the
Figure 4. ROC curves. Receiver-operating-characteristic curves (ROC) were calculated for every significantly different cytokine and cytokine ratio.
AUCs are summarized in Table 2.
doi:10.1371/journal.pone.0035290.g004
T Cell Responses for Diagnosis of Active TB
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35290above mentioned studies were latently infected but apparently
healthy individuals. Thus, it is intriguing, that the value of single
TNF-a producing T cells for diagnosis of active TB is questionable
in different patient groups with initial suspicion of active TB.
Secondly and in contrast to previous investigations, T cells were
co-stained with IFN-c only and not with any other cytokines
[7,9,18]. Therefore, we are not able to directly compare our results
with the data published in the literature as ‘‘single’’ cytokine
producing T cells. Consequently, we used the term ‘‘one cytokine
producing T cell’’ as opposed to ‘‘single cytokine producing T
cell’’. Nevertheless, the complete lack of difference between patient
groups - as shown for example for TNF-a - questions the actual
usefulness of individual cytokines in general despite minor
differences in read out.
The later administration of Brefeldin A (6 hours in our study
instead of 1–2 hours, as reported in [7]) to the stimulatory assay
does not explain the lack of discrimination between the subject
groups, as we have found reliable pro- as well as anti-inflammatory
responses after PPD and ESAT-6 stimulation in all groups.
Additional experiments have also not shown substantial differences
in cytokine expression when Brefeldin A was added 4 hours earlier
(data not shown).
The only significantly increased multifunctional T cell subpop-
ulations were CD4
+IFN-c
+IL-10
+ T cells, when TB patients were
compared to patients with non-TB diseases. Given their relative
reduction in patients with extrapulmonary TB, it is tempting to
speculate about immune-regulatory properties of this cellular
subpopulation. However, CD4
+IFN-c
+IL-10
+ T cells did not
contribute independently to the logistic regression model,
questioning their relevance for diagnostic purposes.
To date, the available data on multi- and polyfunctional MTB
specific T cells during active TB are inconsistent. Different reports
suggested increased [17], decreased [9] and no differences [10] of
multi-functional T cells in active TB if compared to different
control groups. In our clinical cohort, including the by far largest
number of patients published to date, multifunctional T cells were
not associated with the active TB. This finding could be either
explained by the decrease of multiple cytokine producing T cells in
the TB patient group caused by the exhaustion of T cells during
active TB, as suggested earlier in analogy to viral infections
[19,20]. On the contrary, however, this result may also be ex-
plained by an increase of multifunctional T cells in the patient
group suffering from non-TB diseases. Indeed, polyfunctional T
cells were associated with chronic viral infections and vaccine
memory [10,21–23].
Differences between extra-pulmonary and pulmonary TB were
minor when assessing one cytokine expressing CD4
+ T cells and –
unexpectedly - restricted to differences among CD8
+ T cells. These
differences have not been described before, possibly because
differences between pulmonary and extrapulmonary TB were not
subject of many studies. The current data available suggest, for
example, that miliary TB is associated with an immune-regulatory
phenotype [24], whereas pleural TB is associated with a strong,
localized type 1 immune response [4,12]. Regarding CD8
+ T cells,
different concepts exist on their role during infection with MTB
[25]. CD8
+ T cells produce IFN-c and TNF-a upon exposure to
different MTB specificpeptidesinlatent infected individuals [8] and
have been suggested to be associated with disease progression [9].
The distinction between pulmonary TB and extrapulmonary
TB might seem arbitrary, given that the latter is quite a
heterogeneous group of disease manifestations. This classification,
however, has significant clinical impact, because extrapulmonary
TB is thought not to be contagious or at least much less so if
compared to pulmonary TB [26] and has different treatment
Table 2. Summary of receiver-operating-characteristic curves (ROC).
Antigen AUC S.E. Sig. 95% CI
pulmonary TB/other diseases
cytokines
CD4
+ IFN-c
+ ESAT-6 0.644 0.047 0.003 0.551 0.736
IL-2
+ 0.428 0.047 0.136 0.337 0.519
pulmonary TB/other diseases
cytokine-ratios
CD4
+ IFN-c/IL-2 PPD 0.704 0.045 ,0.001 0.617 0.792
TNF-a/IFN-c ESAT-6 0.613 0.048 0.019 0.519 0.706
TNF-a/IL-2 0.593 0.049 0.054 0.497 0.688
IFN-c/IL-2 0.654 0.048 =0.001 0.560 0.747
extrapulmonary TB/other
diseases cytokines
CD4
+ IFN-c
+IL-10
+ PPD 0.439 0.059 0.349 0.324 0.555
IFN-c
+ ESAT-6 0.665 0.067 0.009 0.534 0.795
extrapulmonary TB/other
diseases cytokine-ratios
CD4
+ TNF-a/IL-2 PPD 0.756 0.051 ,0.001 0.657 0.856
IFN-c/IL-2 0.712 0.057 0.001 0.600 0.824
TNF-a/IFN-c ESAT-6 0.648 0.062 0.020 0.527 0.768
TNF-a/IL-2 0.652 0.064 0.017 0.525 0.778
IFN-c/IL-2 0.685 0.063 0.004 0.561 0.809
extrapulmonary TB/pulmonary
TB cytokines
CD8
+ IL-2
+ PPD 0.689 0.067 0.005 0.558 0.819
CD8
+ IFN-c
+TNF-a
+ ESAT-6 0.645 0.067 0.031 0.514 0.776
extrapulmonary TB/pulmonary
TB cytokine-ratios
CD4
+ TNF-a/IL-2 PPD 0.634 0.066 0.045 0.505 0.765
Legends: AUC: area under the curve; S.E.: standard error; Sig.: significance level; CI: confidence interval.
doi:10.1371/journal.pone.0035290.t002
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between the two manifestations of MTB associated diseases exist,
which have to be considered in both immune based diagnostics as
well as vaccine trials.
To our surprise, the highest AUCs after ROC analysis to
discriminate pulmonary and extrapulmonary TB from other
diseases were PPD induced cytokine ratios of IFN-c/IL-2 and
TNF-a/IL-2, respectively. A higher IFN-c/IL-2 ratio has been
reported previously to be associated with untreated TB [18,27,28].
This might be related to a generally higher frequency of PPD
specific T cells in peripheral blood as compared to ESAT-6
specific T cells [6,12–14,29].
In our study cohort, PPD stimulation was followed by a relative
increase of IFN-c over IL-2, which discriminated best between
patient groups and confirmed the presence of an IFN-c secreting,
‘‘effector’’ phenotype of CD4
+ T cells in patients with active TB
[16,30]. Assessment of the TNF-a/IL-2 ratio derived of CD4
+ T
cells revealed increased TNF-a in patients suffering from extra-
pulmonary TB, suggesting a more pro-inflammatory cytokine
profile if compared to pulmonary TB. Thus, the use of cytokine
ratios rather than single cytokine measurements could help to
overcome the pronounced, inter-individual variability of cytokine
responses that currently limit their usefulness for immune-
diagnosis of active TB.
Our study has some drawbacks. The study was not designed
to discriminate between active TB and latent infection but for
defining active TB cases. Moreover, the study design did not allow
interfering or suggesting any interventions which could alter
patient management. Therefore and in accordance with interna-
tional guidelines, a TST was not routinely administered. As a
result, the poor diagnostic performance of MTB specific T cells
for the diagnosis of active TB could also be explained by a high
frequency of latently infected individuals, who also have MTB
specific, polyfunctional T cells detectable in peripheral blood [31].
However, this fact does not alter the conclusions drawn from our
study, because active TB was clearly defined in a large number of
patients. Whether the T cell response of non-TB patients is caused
by latent TB infection, non-tuberculous mycobacteria or by
unspecific immunological activation during neoplastic disease is
insignificant for a tool aiming at defining active TB out of the large
group of TB suspects.
Taken together, our recent study shows in a large clinical cohort
that neither pro- nor anti-inflammatory T cell derived cytokines
are able to discriminate between TB and non-TB-diseases
sufficiently to be suitable as a diagnostic tool. However, cytokine
ratios could introduce an improvement in sensitivity and specificity
Figure 5. Cytokine ratios. Significant differences between different
cytokine ratios are depicted, detected with a one way between-groups
analysis of variance using the tukey test for post hoc analysis. Data from
60 patients with pulmonary TB (light grey), 27 extrapulmonary TB (dark
grey) and 91 with non-tuberculous diseases (white) are depicted. Boxes
and whiskers are displayed, the black line marks the median. Percentile
ranges are additionally shown in Tables 3, 4, 5. (A) shows statistically
significant differences between non-tuberculous diseases and pulmo-
nary TB: PPD induced IFN-c/IL-2 (p,0.001), ESAT-6 induced TNF-a/IFN-c
(p=0.048), TNF-a/IL-2 (p=0.03), IFN-c/IL-2 (p=0.005), all CD4
+ T cell
derived. (B) shows statistically significant differences between non-
tuberculous diseases and extrapulmonary TB: PPD induced TNF-a/IL-2
(p,0.001), IFN-c/IL-2 (p=0.001), ESAT-6 induced TNF-a/IFN-c
(p=0.026), TNF-a/IL-2 (p=0.008), IFN-c/IL-2 (p,0.001), CD4
+ T cell
derived. (C) shows statistically significant differences between pulmo-
nary TB and extrapulmonary TB: PPD induced TNF-a/IL-2 (p=0.001),
CD4
+ T cell derived.
doi:10.1371/journal.pone.0035290.g005
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ities for immune-diagnosis of active TB.
Author Contributions
Conceived and designed the experiments: JN HW SW. Performed the
experiments: JN HW CM SW. Analyzed the data: JN RR LB OB SW.
Contributed reagents/materials/analysis tools: HW RZ RR OB SW.
Wrote the paper: JN SW.
References
1. Lawn SD, Zumla AI (2011) Tuberculosis. Lancet 378: 57–72.
2. Jafari C, Kessler P, Sotgiu G, Ernst M, Lange C (2011) Impact of a
Mycobacterium tuberculosis-specific interferon-c release assay in bronchoalve-
olar lavage fluid for a rapid diagnosis of tuberculosis. J Intern Med 270:
254–262.
3. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, et al. (2011) Interferon-
gamma release assays for the diagnosis of latent Mycobacterium tuberculosis
infection: a systematic review and meta-analysis. Eur Respir J. Switzerland. pp.88–99.
4. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, et al. (2011) Interferon-c
release assays for the diagnosis of active tuberculosis: a systematic review and
meta-analysis. Eur Respir J 37: 100–111.
5. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, et al. (2011) Interferon-c
release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a
systematic review and meta-analysis. Eur Respir J 37: 88–99.
6. Fuhrmann S, Streitz M, Kern F (2008) How flow cytometry is changing the
study of TB immunology and clinical diagnosis. Cytometry A 73: 1100–1106.
7. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, et al. (2011) Dominant
TNF-a+ Mycobacterium tuberculosis-specific CD4+ T cell responses discrim-
inate between latent infection and active disease. Nat Med 17: 372–376.
8. Commandeur S, Lin MY, van Meijgaarden KE, Friggen AH, Franken KL, et al.
(2011) Double- and monofunctional CD4(+) and CD8(+) T-cell responses to
Mycobacterium tuberculosis DosR antigens and peptides in long-term latently
infected individuals. Eur J Immunol 41(10): 2925–36.
9. Day CL, Abrahams DA, Lerumo L, Janse van Rensburg E, Stone L, et al. (2011)
Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses
in Humans Is Associated with Mycobacterial Load. J Immunol 187(5): 2222–32.
10. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, et al. (2010)
Multifunctional CD4(+) T cells correlate with active Mycobacterium tubercu-
losis infection. Eur J Immunol 40: 2211–2220.
11. Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev
Immunol 27: 393–422.
Table 3. Cytokine ratios pulmonary TB/non-tuberculous diseases.
PPD IFN-c/IL-2 ESAT-6 TNF-a/IFN-c ESAT-6 TNF-a/IL-2 ESAT-6 IFN-c/IL-2
non-TB pul-TB non-TB pul-TB non-TB Pul-TB non-TB pul-TB
Minimum 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
25% Percentile 0.4325 0.6650 0.0 0.0 0.0 0.0 0.0 0.0
Median 0.6700 0.9600 0.0 0.5850 0.0 0.6250 0.0 0.5000
75% Percentile 0.9300 1.183 0.6600 1.250 0.5750 1.785 0.5000 1.500
Maximum 2.460 4.000 3.880 6.000 3.000 7.600 1.750 3.580
doi:10.1371/journal.pone.0035290.t003
Table 4. Cytokine ratios extrapulmonary TB/non-tuberculous diseases.
PPD TNF-a/IL-2 PPD IFN-c/IL2 ESAT-6 TNF-a/IL-2 ESAT-6 IFN-c/IL-2 ESAT-6 TNF-a/IFN-c
non-TB extra-TB non-TB extra-TB non-TB Extra-TB non-TB extra-TB non-TB extra-TB
Minimum 0.0 1.140 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
25% Percentile 0.9050 1.540 0.4350 0.7075 0.0 0.0 0.0 0.0 0.0 0.0
Median 1.270 2.270 0.6700 1.000 0.0 0.5000 0.0 0.2500 0.0 0.5714
75% Percentile 1.640 3.840 0.9350 1.438 0.6150 1.150 0.5000 1.230 0.6250 1.091
Maximum 5.670 10.83 2.460 4.000 3.000 9.000 1.750 5.330 3.000 6.000
doi:10.1371/journal.pone.0035290.t004
Table 5. Cytokine ratios pulmonary TB/extrapulmonary TB.
PPD TNF-a/IL-2
pul-TB extra-TB
Minimum 0.0 1.140
25% Percentile 1.243 1.540
Median 1.525 2.200
75% Percentile 2.133 3.818
Maximum 12.00 10.83
doi:10.1371/journal.pone.0035290.t005
T Cell Responses for Diagnosis of Active TB
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e3529012. Nemeth J, Winkler HM, Boeck L, Adegnika AA, Clement E, et al. (2011)
Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin
Immunol 138: 50–59.
13. Winkler S, Necek M, Winkler H, Adegnika AA, Perkmann T, et al. (2005)
Increased specific T cell cytokine responses in patients with active pulmonary
tuberculosis from Central Africa. Microbes Infect 7: 1161–1169.
14. Nemeth J, Winkler HM, Zwick RH, Rumetshofer R, Schenk P, et al. (2009)
Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of
infection for diagnosis of active tuberculosis. J Intern Med 265: 163–168.
15. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An
interferon-inducible neutrophil-driven blood transcriptional signature in human
tuberculosis. Nature 466: 973–977.
16. Sallusto F, Lenig D, Fo ¨rster R, Lipp M, Lanzavecchia A (1999) Two subsets of
memory T lymphocytes with distinct homing potentials and effector functions.
Nature 401: 708–712.
17. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO (2009) Pattern and
diversity of cytokine production differentiates between Mycobacterium tuber-
culosis infection and disease. Eur J Immunol 39: 723–729.
18. Sester U, Fousse M, Dirks J, Mack U, Prasse A, et al. (2011) Whole-blood flow-
cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes
active tuberculosis from non-active states. PLoS One 6: e17813.
19. Ciuffreda D, Comte D, Cavassini M, Giostra E, Bu ¨hler L, et al. (2008)
Polyfunctional HCV-specific T-cell responses are associated with effective
control of HCV replication. Eur J Immunol 38: 2665–2677.
20. Kannanganat S, Kapogiannis BG, Ibegbu C, Chennareddi L, Goepfert P, et al.
(2007) Human immunodeficiency virus type 1 controllers but not noncontrollers
maintain CD4 T cells coexpressing three cytokines. J Virol 81: 12071–12076.
21. Young JM, Adetifa IM, Ota MO, Sutherland JS (2010) Expanded polyfunc-
tional T cell response to mycobacterial antigens in TB disease and contraction
post-treatment. PLoS One 5: e11237.
22. Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, et al. (2008)
Yellow fever vaccine induces integrated multilineage and polyfunctional
immune responses. J Exp Med 205: 3119–3131.
23. Duvall MG, Precopio ML, Ambrozak DA, Jaye A, McMichael AJ, et al. (2008)
Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol
38: 350–363.
24. Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, et al. (2009) FoxP3+
regulatory T cells suppress effector T-cell function at pathologic site in miliary
tuberculosis. Am J Respir Crit Care Med 179: 1061–1070.
25. Grotzke JE, Lewinsohn DM (2005) Role of CD8+ T lymphocytes in control of
Mycobacterium tuberculosis infection. Microbes Infect 7: 776–788.
26. Herna ´ndez-Gardun ˜o E, Cook V, Kunimoto D, Elwood RK, Black WA, et al.
(2004) Transmission of tuberculosis from smear negative patients: a molecular
epidemiology study. Thorax 59: 286–290.
27. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, et al. (2007)
Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium
tuberculosis-specific T cells and antigen load. J Immunol 178: 5217–5226.
28. Krummel B, Strassburg A, Ernst M, Reiling N, Eker B, et al. (2010) Potential
role for IL-2 ELISpot in differentiating recent and remote infection in
tuberculosis contact tracing. PLoS One 5: e11670.
29. Streitz M, Tesfa L, Yildirim V, Yahyazadeh A, Ulrichs T, et al. (2007) Loss of
receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis.
PLoS One 2: e735.
30. Harari A, Vallelian F, Meylan PR, Pantaleo G (2005) Functional heterogeneity
of memory CD4 T cell responses in different conditions of antigen exposure and
persistence. J Immunol 174: 1037–1045.
31. Nemeth J, Winkler HM, Karlhofer F, Selenko-Gebauer N, Graninger W, et al.
(2010) T cells co-producing Mycobacterium tuberculosis-specific type 1
cytokines for the diagnosis of latent tuberculosis. Eur Cytokine Netw 21: 34–39.
T Cell Responses for Diagnosis of Active TB
PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e35290